SMTL ID : 5l6o.1

EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 3)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.88 Å

Oligo State

monomer

Ligands

1 x 6P6: 1-(4-phenylazanylquinazolin-7-yl)ethanone(Covalent)

6P6.1: 14 residues within 4Å: Chain A: I.27, V.35, A.51, K.53, M.74, I.97, T.99, E.100, F.101, M.102, C.105, L.153, S.163, D.164 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.35, A:A.51, A:K.53, A:I.97, A:T.99, A:F.101, A:F.101 Hydrogen bonds: A:T.99, A:M.102 Water bridges: A:A.106, A:L.167

1 x DIO: 1,4-DIETHYLENE DIOXIDE(Non-covalent)

DIO.2: 9 residues within 4Å: Chain A: M.74, F.77, I.82, I.83, Y.142, H.144, V.162, S.163, F.165 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kung, A. et al., Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine Kinase EphB3. J.Am.Chem.Soc. (2016)

Release Date

2016-08-10

Peptides

Ephrin type-B receptor 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Ephrin type-B receptor 3

Related Entries With Identical Sequence